AGP Executive Report
Last update: 9 hours agoVaccine Trial Dispute: Guinea-Bissau’s health minister says the government has not authorized a proposed hepatitis B study in 14,000 newborns, despite researchers reporting ethics approval for a revised plan. The trial would delay the birth dose for half the babies until six weeks; researchers say infants whose mothers have hepatitis B would be excluded. Energy Data Technology: TGS has secured rights to reprocess more than 11,000 square kilometres of Guinea-Bissau’s JAAN 3D seismic data with PetroGuin, using advanced imaging methods. Work is due to start in late 2026, with results expected in 2027. Regional Connectivity: Guinea says AfDB-backed road projects linking it with Guinea-Bissau and Sierra Leone are helping turn AfCFTA plans into practical cross-border trade routes.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
